Use your antibodies-online credentials, if available.
SH3BGRL3 is a novel urinary biomarker for urothelial carcinoma. Evaluation of SH3BGRL3 expression status may identify a subset of patients with urothelial carcinoma for cotargeting candidates in the design of EGFR-based cancer therapies.
SH3BGRL3 may function as a regulator in all-trans retinoic acid-induced pathway
Could act as a modulator of glutaredoxin biological activity (By similarity).
SH3 domain-binding glutamic acid-rich-like protein 3
, SH3 domain-binding protein 1
, SH3BGRL3-like protein
, TNF inhibitory protein